TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Avalon GloboCare ( (ALBT) ) has provided an update.
On June 4, 2025, Avalon GloboCare entered into a securities purchase agreement with York Sun Investment Holding Limited to sell 141,643 shares of common stock for $500,000, with the closing expected by June 6, 2025. Additionally, the company secured a waiver from Mast Hill Fund, L.P. on May 29, 2025, regarding potential cash penalties related to a previous issuance of Series C Convertible Preferred Stock, while maintaining certain dilutive issuance rights.
More about Avalon GloboCare
Avalon GloboCare Corp. is a Delaware-based company involved in the biotechnology and healthcare industry, focusing on the development of innovative cellular therapies and related technologies.
Average Trading Volume: 57,731
Technical Sentiment Signal: Sell
Current Market Cap: $6.89M
For an in-depth examination of ALBT stock, go to TipRanks’ Stock Analysis page.